Press Releases Year None2022202120202019201820172016 Gamida Cell Announces Closing of $25 Million Financing With Highbridge December 12, 2022 PDF Version View HTML Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences November 23, 2022 PDF Version View HTML Gamida Cell Provides Regulatory Update on Omidubicel November 21, 2022 PDF Version View HTML Gamida Cell Reports Third Quarter 2022 Financial Results and Provides Company Update November 14, 2022 PDF Version View HTML Gamida Cell to Present Corporate Highlights at the Jefferies London Healthcare Conference November 10, 2022 PDF Version View HTML GDA-501, NAM enabled NK Cell Therapy, Demonstrates Promising Antitumor Activity Against HER2+ Cancers November 7, 2022 PDF Version View HTML Gamida Cell Announces the Date of Its Third Quarter 2022 Financial Results and Webcast November 7, 2022 PDF Version View HTML Gamida Cell Announces Omidubicel Data To Be Presented as an Oral Presentation at 64th ASH Annual Meeting November 3, 2022 PDF Version View HTML Gamida Cell to Present Corporate Highlights at 2022 Cell & Gene Meeting on the Mesa October 10, 2022 PDF Version View HTML Long-Term Data from Omidubicel Phase 3 Trial Demonstrates Overall Survival and Sustainable Durable Outcomes for Patients with Blood Cancers at the Society of Hematologic Oncology Meeting September 29, 2022 PDF Version View HTML Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page next › Last page last » Displaying 1 - 10 of 41
